Company Overview and News

 
Cazaly Resources extends cobalt prospective land position in Namibia

2018-05-03 proactiveinvestors.com.au
Cazaly Resources Limited (ASX:CAZ) has completed the acquisition of the Kaoko Kobalt project in the Kunene Cobalt Province, northern Namibia.

 
Cazaly Resources surges on copper-cobalt acquisition option

2017-12-19 proactiveinvestors.com.au
Cazaly Resources Limited’s (ASX:CAZ) intention to purchase a copper-cobalt prospect in Namibia sparked a 76% surge in shares on Tuesday.

 
Cazaly Resources snaps up new project

2017-12-15 proactiveinvestors.com.au
Cazaly Resources Ltd (ASX: CAZ) is preparing to reveal details of a project acquisition, and the ASX has granted the company a trading halt.

 
Cazaly Resources’ shares surge on sampling high-grade cobalt at Bungonia

2017-11-30 proactiveinvestors.com.au
Cazaly Resources Limited (ASX:CAZ) has intersected high grade cobalt from first pass reconnaissance mapping and rock chip sampling at its Bungonia cobalt project in New South Wales.

 
Cazaly Resources heads to market following cobalt acquisition

2017-05-04 proactiveinvestors.com.au
Cazaly Resources (ASX:CAZ) has been granted a trading halt by the ASX, pending details of a capital raising.

 
Lithium Australian NL trademark application accepted for LieNa™

2017-01-02 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) has had its trademark application for its 100% owned  LieNA™ lithium extraction process accepted for registration.

 
Lithium Australia NL and partner leap out of starting box in Mexico

2016-12-08 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) is earning a 49% stake Electra project at Sonora in northwest Mexico, and has an option to extend that to 65% from project owner, Canada’s Alix Resources Corp (AIX-TSX:V).

 
Cazaly Resources sets sight on cobalt in Queensland and New South Wales

2016-12-07 proactiveinvestors.com.au
Both licences cover several prospects with significant historic cobalt mineralisation with little modern exploration conducted to date. In New South Wales, the Bungonia Project covers about 240 square kilometres on the eastern edge of the Lachlan Fold Belt. Previous exploration defined several areas of significant cobalt and nickel mineralisation, some of which have been historically mined as early as the 1890’s.

 
Lithium Australia NL continues quest to build globally significant footprint

2016-11-11 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) is now the 100% owner of the Greenbushes lithium project which is adjacent to the globally significant lithium mine owned by Talisman Lithium.

 
Lithium Australia NL extends Share Purchase Plan

2016-11-07 proactiveinvestors.com.au
Adrian Griffin, managing director, commented: “Lithium Australia has maintained a policy of creating real value for shareholders.

 
Lithium Australia NL identifies new anomaly at Seabrook

2016-11-04 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) has used its experience in geochemical modelling of prospective lithium terrains to identify a new lithium target within the Seabrook Rare Metals Venture in Western Australia.

 
Lithium Australian NL’s Sileach™ process to fuel industrial revolution

2016-10-27 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) has produced 6 kilograms of 99% lithium carbonate concentrate using its proprietary lithium extraction process, Sileach.

 
Lithium Australia NL continues to build lithium war chest

2016-10-25 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) continues to add to its portfolio of lithium prospects by discovering lithium bearing pegmatites at its Lake Johnston project in Western Australia.

 
Lithium Australia NL receives break-through from Sileach™ pilot plant

2016-10-07 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) has achieved exceptional lithium extraction results from its six-day pilot plant program testing its 100% owned Sileach™ lithium extraction process. Testing has been conducted at the ANSTO Minerals facility in New South Wales and 650 kilograms of ore was processed. The campaign produced a purified lithium-containing liquor, devoid of impurities. This purified liquor will be processed through to high-purity lithium carbonate in a second pilot campaign in the near future.

 
Lithium Australia NL receives break-through from Sileach™ pilot plant

2016-10-04 proactiveinvestors.com.au
Lithium Australia NL (ASX:LIT) has achieved exceptional lithium extraction results from its six-day pilot plant program testing its 100% owned Sileach™ lithium extraction process. Testing has been conducted at the ANSTO Minerals facility in New South Wales and 650 kilograms of ore was processed. The campaign produced a purified lithium-containing liquor, devoid of impurities. This purified liquor will be processed through to high-purity lithium carbonate in a second pilot campaign in the near future.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...